article thumbnail

Inside the Movement to Transform and Democratize Health Care With AI

Success

These conditions affect small patient populations and historically receive little attention from the pharmaceutical industry due to limited commercial incentive. Their biggest risk is not having enough cash to make payroll or interest payments.” AI is helping shift this paradigm.

article thumbnail

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

Mad in America

For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. The marketing of medical conditions has become a key plank of pharmaceutical industry marketing. Helping widen the definitions of disease is a key part of marketing those pharmaceutical products.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

3 middle class families across America share what they earn, spend, and save

Work Life

Louis Science Center,  and one child, age 16Location: St.

Insurance 111
article thumbnail

The Lie That Antidepressants Protect Against Suicide Is Deadly

Mad in America

Gibbons has been an expert witness in lawsuits for two pharmaceutical companies that sell antidepressants. The pharmaceutical companies have also hidden many suicides and suicide attempts in their clinical trials. Therefore, many suicides are never reported. This cannot be called a “possibly slightly increased risk.”

article thumbnail

Suicides Increase After National Suicide Prevention Introduced

Mad in America

Studies that happen to show that depression drugs protect against suicide have a far greater likelihood of being published than studies that show the opposite, as the prevailing belief among top psychiatristswho are very often on industry payroll and in the drug industry is that the drugs are protective.

Payroll 137